Search results
Merck acquires EyeBio in up to $3B deal By Proactive Investors
Investing.com· 7 days agoMerck & Co Inc (NYSE:MRK, ETR:6MK) announced it is acquiring Eyebio, a privately held...
Former GE General Counsel Joins Paul Weiss As Partner
LawFuel· 3 hours agoPaul, Weiss, Rifkind, Wharton & Garrison LLP announced today that Michael Holston will join the firm...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters· 2 days ago, opens new tab said on Monday their cancer vaccine in combination with blockbuster cancer therapy...
Summit Therapeutics stock rallies as institutional buyer loads up on shares | Invezz
Invezz· 2 days agoSummit Therapeutics Inc (NASDAQ: SMMT) says it raised $200 million via an offer it accepted from an...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters via Yahoo News· 2 days agoDetailed data on Monday from the 157-patient trial showed that after two and a half years, melanoma...
Summit Therapeutics’ stock surges as lung-cancer treatment vies with Merck’s blockbuster
Market Watch· 6 days agojumped more than 270% Thursday after the company said its experimental cancer drug outperformed ...
Summit Shares Soar After Cancer Drug Tops Merck’s Keytruda
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- Summit Therapeutics Inc. shares jumped after the biotech company said a late-stage...
Chasing Merck, AstraZeneca's PCSK9 inhibitor lowers cholesterol in phase 1 test
FierceBiotech· 7 days agoAstraZeneca’s small molecule lowered levels of “bad” cholesterol by more than half in patients who...
What drug manufacturer Lonza plans to do with Genentech's soon-to-be-former Vacaville site - San...
The Business Journals· 15 hours agoThe deal, announced in March, remains in the process of regulatory approval, said Hyvert, who noted...
US Duo Takes On Merck's $3B Acquisition Of EyeBio | Law.com International
Law.com· 6 days agoSkadden Arps Slate Meagher & Flom and Gibson Dunn & Crutcher have taken on lead roles in New...